|
Oxylipins - Metabolites of Linoleic and Linolenic Acid Definitions "Oxylipin" has been introduced as a collective term for oxygenated compounds biosynthesized from fatty acids by sequences involving at least one step of mono- or dioxygenase-catalyzed oxygenation. A large part of oxylipins in animals or plants is biosynthesized from polyunsaturated fatty acids by action of enzyme(s) of the dioxygenase type. Further conversion of the resulting unstable peroxide or hydroperoxide derivatives results in a range of compounds often exerting potent
biological effects.
Biological Significance In the animal kingdom, the C20 fatty acid arachidonic acid serves as the most important precursor of oxygenated derivatives, compounds commonly referred to as "eicosanoids" (gr. eicosa, twenty) because of their carbon chain length. Primary oxygenation of arachidonic acid and other fatty acids in animal tissue is mainly catalyzed by prostaglandin endoperoxide synthases1 and lipoxygenases2 leading to a number of oxygenated derivatives such as prostaglandin H2, leukotriene A4, and various fatty acid hydroperoxides. These intermediates are further modified by secondary enzymes including prostaglandin E, D, and F synthases, thromboxane A synthase, prostacyclin synthase, leukotriene A4 hydrolase, and leukotriene C4 synthase to generate members of the prostaglandin, leukotriene and thromboxane families3. Another pathway involves primary
oxygenation by enzymes of the monooxygenase type leading to the formation of
epoxy, hydroxy, and dihydroxy derivatives3. Non-enzymatical oxygenation of
arachidonic acid and other polyunsaturated fatty acids can also take place
resulting in the isoprostane group of compounds4. Current Research Intense research is devoted to the chemistry, biochemistry, and molecular biology of oxylipins. Participation of these compounds in inflammation, hemostasis and possibly certain malignancies such as colon cancer has led to the development of several new drugs including COX-2 inhibitors and antileukotrienes. Literature references 1. Marnett, L.J., Rowlinson, S.W., Goodwin, D.C., Kalgutkar, A.S., and Lanzo, C.A. (1999) Arachidonic Acid Oxygenation by COX-1 and COX-2, J. Biol. Chem. 274, 22903-22906. 2. Brash, A.R. (1999) Lipoxygenases: Occurrence, Functions, Catalysis, and Acquisition of Substrate, J. Biol. Chem. 274, 23679-23682. 3. Needleman, P., Turk, J., Jakschik, B.A., Morrison, A.R., and Lefkowith, J.B. (1986) Arachidonic Acid Metabolism, Ann. Rev. Biochem. 55, 69-102. 4. Lawson, J.A., Rokach, J., and FitzGerald, G.A. (1999) Isoprostanes: Formation, Analysis and Use as Indices of Lipid Peroxidation in Vivo, J. Biol. Chem. 274, 24441-24444. 5. Gardner, H.W. (1988) Recent Investigations into the Lipoxygenase Pathway of Plants, Biochim. Biophys. Acta 1084, 221-239. 6. Grechkin, A. (1998) Recent Developments in Biochemistry of the Plant Lipoxygenase Pathway, Prog. Lipid Res. 37, 317-352. 7. Blée, E. (1998) Phytooxylipins and Plant Defense Reactions, Prog. Lipid Res. 37, 33-72. 8. Hamberg, M., and Gardner, H.W. (1992) Oxylipin Pathway to Jasmonates: Biochemistry and Biological Significance, Biochim. Biophys. Acta 1165, 1-18. 9. Mueller, M.J. (1998) Radically Novel Prostaglandins in Animal and Plants: the Isoprostanes, Chemistry & Biology 5, R323-R333. ![]() ![]() ![]() ©2001 Larodan Fine Chemicals AB. All rights reserved. http://www.larodan.se
|